Artificial intelligence and pathology: from principles to practice and future applications in histomorphology and molecular profiling

A Stenzinger, M Alber, M Allgäuer, P Jurmeister… - Seminars in cancer …, 2022 - Elsevier
The complexity of diagnostic (surgical) pathology has increased substantially over the last
decades with respect to histomorphological and molecular profiling. Pathology has steadily …

Clinical and analytical validation of FoundationOne®CDx, a comprehensive genomic profiling assay for solid tumors

CA Milbury, J Creeden, WK Yip, DL Smith, V Pattani… - PLoS …, 2022 - journals.plos.org
FoundationOne® CDx (F1CDx) is a United States (US) Food and Drug Administration (FDA)-
approved companion diagnostic test to identify patients who may benefit from treatment in …

[HTML][HTML] Molecular profiling in cholangiocarcinoma: a practical guide to next-generation sequencing

A Stenzinger, A Vogel, U Lehmann, A Lamarca… - Cancer Treatment …, 2024 - Elsevier
Cholangiocarcinomas (CCA) are a heterogeneous group of tumors that are classified as
intrahepatic, perihilar, or distal according to the anatomic location within the biliary tract …

Integrating somatic and germline next-generation sequencing into routine clinical oncology practice

JK Hicks, R Howard, P Reisman, JJ Adashek… - JCO precision …, 2021 - ascopubs.org
Next-generation sequencing (NGS) is rapidly expanding into routine oncology practice.
Genetic variations in both the cancer and inherited genomes are informative for hereditary …

Virtual multidisciplinary tumor boards: a narrative review focused on lung cancer

V Gebbia, A Guarini, D Piazza, A Bertani, M Spada… - Pulmonary …, 2021 - Springer
To date, the virtual multidisciplinary tumor boards (vMTBs) are increasingly used to achieve
high-quality treatment recommendations across health-care regions, which expands and …

High‐throughput molecular assays for inclusion in personalised oncology trials–State‐of‐the‐art and beyond

A Edsjö, HG Russnes, J Lehtiö… - Journal of internal …, 2024 - Wiley Online Library
In the last decades, the development of high‐throughput molecular assays has
revolutionised cancer diagnostics, paving the way for the concept of personalised cancer …

[HTML][HTML] Fighting cancer around the world: A framework for action

D Horgan, R Mia, T Erhabor, Y Hamdi, C Dandara… - Healthcare, 2022 - mdpi.com
Tackling cancer is a major challenge right on the global level. Europe is only the tip of an
iceberg of cancer around the world. Prosperous developed countries share the same …

Envisioning the future of precision oncology trials

S Madhavan, RA Beckman, MD McCoy, MJ Pishvaian… - Nature Cancer, 2021 - nature.com
Precision oncology trials based on cancer biomarkers have the potential to improve
outcomes by guiding the optimal choice of therapies for patients. For this to be truly …

[HTML][HTML] Recommendations for the use of next-generation sequencing and the molecular tumor board for patients with advanced cancer: a report from KSMO and …

S Yoon, M Kim, YS Hong, HS Kim… - … : Official Journal of …, 2022 - synapse.koreamed.org
Next-generation sequencing (NGS) is becoming essential in the fields of precision oncology.
With implementation of NGS in daily clinic, the needs for continued education, facilitated …

Knowledge bases and software support for variant interpretation in precision oncology

F Borchert, A Mock, A Tomczak, J Hügel… - Briefings in …, 2021 - academic.oup.com
Precision oncology is a rapidly evolving interdisciplinary medical specialty. Comprehensive
cancer panels are becoming increasingly available at pathology departments worldwide …